Invopressin

N/A

Report date: 2025/05/23 17:57:30

Base Information

Drug NameInvopressin
Drug Alias NameOCE-205
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasopressin V1a receptor antagonistsVasopressin V1a receptor agonists
TargetsVasopressin V1a receptor
Therapy Area/IndicationsAscitesAcute Kidney InjuryLiver Cirrhosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOcelot Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesOcelot Bio Inc
Inactive CompaniesN/A
Active IndicationsAscitesAcute Kidney InjuryLiver Cirrhosis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A